- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4/A Registration of securities issued in business combination transactions
- 8.1 EX-8.1
- 8.2 EX-8.2
- 10.42 EX-10.42
- 10.43 EX-10.43
- 10.44 EX-10.44
- 10.47 EX-10.47
- 23.1 EX-23.1
- 23.2 EX-23.2
- 99.3 EX-99.3
- 99.4 EX-99.4
- 99.5 EX-99.5
- 99.6 EX-99.6
- 99.7 EX-99.7
- 99.10 EX-99.10
- Download Excel data file
- View Excel data file
- 6 May 24 EFFECT Notice of effectiveness
- 3 May 24 424B3 Prospectus supplement
- 29 Apr 24 S-4/A Registration of securities issued in business combination transactions (amended)
-
15 Apr 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 25 Mar 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 13 Feb 24 S-4 Registration of securities issued in business combination transactions
Exhibit 99.7
Consent to be Named as a Director
In connection with the filing by AVROBIO, Inc. (the “Company”) of the Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named in the Registration Statement and any and all amendments and supplements thereto as a person who has agreed to serve as a director of the Company following its merger with Tectonic Therapeutic, Inc. (which shall be known as Tectonic Therapeutic, Inc.) as described in the Registration Statement. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
Dated: April 15, 2024
By: | /s/ Alise Reicin | |
Name: | Alise Reicin |